NCT00416546View on ClinicalTrials.gov

Safety of AEB071 in Healthy Volunteers and to Compare the Ethnicity, Metabolic, and Safety Effects Between Caucasian and Japanese Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

October 31, 2006

Study Completion Date

October 31, 2007

Conditions
Healthy
Interventions
DRUG

AEB071

Trial Locations (1)

Unknown

Novartis Investigative Site, Dorval

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY